Brief: Evofem Biosciences Received A Written Notice From Nasdaq That It Has Determined To Delist Co's Securities

Evofem Biosciences

10/08/2022 14:39

Aug 10 (Reuters) - Evofem Biosciences Inc  EVFM.O :
    * EVOFEM BIOSCIENCES - ON AUGUST 9, RECEIVED A WRITTEN NOTICE FROM NASDAQ
THAT IT
HAS DETERMINED TO DELIST CO'S SECURITIES FROM NASDAQ CAPITAL MARKET
    * EVOFEM BIOSCIENCES INC - NASDAQ WILL SUSPEND TRADING IN COMPANY'S
SECURITIES
EFFECTIVE AT OPEN OF BUSINESS ON AUGUST 11, 2022
    * EVOFEM BIOSCIENCES INC - COMPANY REMAINS A PUBLIC COMPANY AND WILL RETAIN
"TICKER" SYMBOL "EVFM."
    * EVOFEM BIOSCIENCES INC - EXPECTS SHARES OF ITS COMMON STOCK WILL COMMENCE
TRADING ON OTC MARKETS GROUP PLATFORM AT OPEN OF TRADING ON AUGUST 11, 2022
    * EVOFEM BIOSCIENCES INC - PLANS TO APPLY FOR TRADING OF ITS SHARES OF
COMMON
STOCK ON OTCQB MARKET

Source text for Eikon:  ID: 
Further company coverage:  EVFM.O 

 ((Reuters.Briefs@thomsonreuters.com;))